Authors

• Xin Du (ORCID: https://orcid.org/0000-0002-9004-8758)
• Huanling Zhu (ORCID: https://orcid.org/0000-0002-5226-3828)
• Yu Hu (ORCID: https://orcid.org/0000-0002-2815-4568)
• Lichuang Men (ORCID: https://orcid.org/0009-0007-5530-7869)
• Weiming Li (ORCID: https://orcid.org/0000-0001-6276-1989)
• Na Xu (ORCID: https://orcid.org/0000-0001-6280-0546)
• Lu Yu (ORCID: https://orcid.org/0000-0002-0256-3275)
• Xiaoli Liu (ORCID: https://orcid.org/0000-0001-8511-9761)
• Yanli Zhang (ORCID: https://orcid.org/0000-0002-8942-5325)
• Qian Jiang (ORCID: https://orcid.org/0000-0001-7131-0522)
• Meng Li (ORCID: https://orcid.org/0000-0002-0441-488X)
• Song Yongping (ORCID: https://orcid.org/0000-0002-0513-4556)
• Bingcheng Liu (ORCID: https://orcid.org/0000-0002-4605-7040)
• Suning Chen

Institutions

• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Peking University (CN)
• Sichuan University (CN)
• Zhengzhou University (CN)
• Soochow University (CN)
• West China Hospital of Sichuan University (CN)
• Nanfang Hospital (CN)
• Peking University People's Hospital (CN)
• Wuhan Union Hospital (CN)
• Institute of Hematology & Blood Diseases Hospital (CN)
• First Affiliated Hospital of Soochow University (CN)
• Tongji Hospital (CN)
• Shenzhen Second People's Hospital (CN)
• Huazhong University of Science and Technology (CN)
• Southern Medical University (CN)

Publication Details

Journal

Cancer

Published

2024-11-26

DOI

https://doi.org/10.1002/cncr.35652

Citations

5

Primary Topic

Chronic Myeloid Leukemia Treatments

Type

article

Field-Weighted Citation Impact

2.27

Funders

• National Natural Science Foundation of China